Actemra was first approved by the FDA in January 2010, and the annual costs of Actemra, depending on the dosage, can range from around $8,000 to over $18,400 without insurance
And eventually, I want to be able to point people toward a short list of companies that are genuinely doing right by this community
For instance, iron overload can enhance chondrocyte catabolism through overactivated NLRP3 inflammasomes, promoting MMP expression and exacerbating cartilage degeneration ( Recent studies have established a close relationship between ferroptosis and ECM degradation (Wilkinson et al., 2019)
However, like all medications, Wegovy carries potential side effects that patients and healthcare professionals should understand thoroughly before commencing treatment
Please read our disclosure for more info